COPD: A stepwise or a hit hard approach?

被引:12
作者
Ferreira, A. J. [1 ,2 ]
Reis, A. [3 ]
Marcal, N. [4 ]
Pinto, P. [5 ,6 ]
Barbara, C. [5 ,6 ]
机构
[1] Ctr Hosp Univ Coimbra, Dept Pulmonol, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, P-3000 Coimbra, Portugal
[3] Ctr Hosp Tondela Viseu, EPE, Dept Pulmonol, Tondela, Portugal
[4] Hosp Vila Franca de Xira, Dept Pulmonol, Vila Franca De Xira, Portugal
[5] Ctr Hosp Lisboa Norte, Chest Dept, Lisbon, Portugal
[6] Univ Lisbon, Fac Med, Environm Hlth Inst ISAMB, P-1699 Lisbon, Portugal
关键词
COPD; Stepwise; Hit hard; Step-up; KS withdrawal; Brencheditaters; ICS; OBSTRUCTIVE PULMONARY-DISEASE; INHALED FLUTICASONE FUROATE; REGULAR PHYSICAL-ACTIVITY; ONCE-DAILY INDACATEROL; SHORT-TERM RESPONSE; DOUBLE-BLIND; SALMETEROL/FLUTICASONE PROPIONATE; SPUTUM-EOSINOPHILIA; SECONDARY ANALYSIS; TIOTROPIUM;
D O I
10.1016/j.rppnen.2015.12.012
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Current guidelines differ slightly on the recommendations for treatment of Chronic Obstructive Pulmonary Disease (COPD) patients, and although there are some undisputed recommendations, there is still debate regarding the management of COPD. One of the hindrances to deciding which therapeutic approach to choose is late diagnosis or misdiagnosis of COPD. After a proper diagnosis is achieved and severity assessed, the choice between a stepwise or "hit hard" approach has to be made. For GOLD A patients the stepwise approach is recommended, whilst for B, C and D patients this remains debatable. Moreover, in patients for whom inhaled corticosteroids (ICS) are recommended, a step-up or "hit hard" approach with triple therapy will depend on the patient's characteristics and, for patients who are being over-treated with ICS, ICS withdrawal should be performed, in order to optimize therapy and reduce excessive medications. This paper discusses and proposes stepwise, "hit hard", step-up and ICS withdrawal therapeutic approaches for COPD patients based on their GOLD group. We conclude that all approaches have benefits, and only a careful patient selection will determine which approach is better, and which patients will benefit the most from each approach. (C) 2016 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:214 / 221
页数:8
相关论文
共 67 条
  • [1] Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial
    Aaron, Shawn D.
    Vandemheen, Katherine L.
    Fergusson, Dean
    Maltais, Francois
    Bourbeau, Jean
    Goldstein, Roger
    Balter, Meyer
    O'Donnell, Denis
    McIvor, Andrew
    Sharma, Sat
    Bishop, Graham
    Anthony, John
    Cowie, Robert
    Field, Stephen
    Hirsch, Andrew
    Hernandez, Paul
    Rivington, Robert
    Road, Jeremy
    Hoffstein, Victor
    Hodder, Richard
    Marciniuk, Darcy
    McCormack, David
    Fox, George
    Cox, Gerard
    Prins, Henry B.
    Ford, Gordon
    Bleskie, Dominique
    Doucette, Steve
    Mayers, Irvin
    Chapman, Kenneth
    Zamel, Noe
    FitzGerald, Mark
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) : 545 - U15
  • [2] Inhaled steroids in COPD: when should they be used?
    Agusti, Alvar
    Fabbri, Leonardo M.
    [J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (11) : 869 - 871
  • [3] Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
    Agusti, Alvar
    Edwards, Lisa D.
    Celli, Bartolome
    MacNee, William
    Calverley, Peter M. A.
    Muellerova, Hana
    Lomas, David A.
    Wouters, Emiel
    Bakke, Per
    Rennard, Steve
    Crim, Courtney
    Miller, Bruce E.
    Coxson, Harvey O.
    Yates, Julie C.
    Tal-Singer, Ruth
    Vestbo, Jorgen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 636 - 646
  • [4] [Anonymous], GLOB STRAT DIAGN MAN
  • [5] Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study
    Bateman, Eric D.
    Ferguson, Gary T.
    Barnes, Neil
    Gallagher, Nicola
    Green, Yulia
    Henley, Michelle
    Banerji, Donald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1484 - 1494
  • [6] Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study
    Beeh, Kai-Michael
    Korn, Stephanie
    Beier, Jutta
    Jadayel, Dalal
    Henley, Michelle
    D'Andrea, Peter
    Banerji, Donald
    [J]. RESPIRATORY MEDICINE, 2014, 108 (04) : 584 - 592
  • [7] Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial
    Brightling, CE
    Monteiro, W
    Ward, R
    Parker, D
    Morgan, MDL
    Wardlaw, AJ
    Pavord, ID
    [J]. LANCET, 2000, 356 (9240) : 1480 - 1485
  • [8] Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease
    Brightling, CE
    McKenna, S
    Hargadon, B
    Birring, S
    Green, R
    Siva, R
    Berry, M
    Parker, D
    Monteiro, W
    Pavord, ID
    Bradding, P
    [J]. THORAX, 2005, 60 (03) : 193 - 198
  • [9] Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
    Buhl, R.
    Dunn, L. J.
    Disdier, C.
    Lassen, C.
    Amos, C.
    Henley, M.
    Kramer, B.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) : 797 - 803
  • [10] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 775 - 789